Skip to main content
SpringerLink
Log in

Bevacizumab/doxorubicin liposomal

Reversible posterior leukoencephalopathy syndrome: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Bürki F, Badie K, Bartoli P, Bernard P, Montastruc JL, Bagheri H.Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen. British Journal of Clinical Pharmacology 65: 793-794, No. 5, May 2008 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab/doxorubicin liposomal. React. Wkly. 1191, 6 (2008). https://doi.org/10.2165/00128415-200811910-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811910-00015

Keywords

Search

Navigation